tirzepatide news october 18 2025 on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Among patients who were eligible

For weight management, NICE has approved semaglutide (Wegovy) for adults with specific BMI criteria (35 kg/m or 30 kg/m with weight-related comorbidities) within specialist weight management services

The other is part of the conversation around new weight loss medications and the future of obesity care

From my perspective as a fellow manufacturer in the skincare industry, what immediately catches my attention is how strongly iCare structures its entire business around removing friction from the launch process

Symptoms can include rash, itching, or, in severe cases, anaphylaxis

GIP/GLP-1/GCGR, triple glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptor agonist

un anabolizante esteroideo introduce sustancias hormonales o farmacolgicas con un efecto y un riesgo completamente distintos